• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. TABOTAMP SNOW ABS; HEMOSTATIC AGENT, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. TABOTAMP SNOW ABS; HEMOSTATIC AGENT, ABSORBABLE Back to Search Results
Catalog Number T2091
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Granuloma (1876); Paresis (1998)
Event Type  Injury  
Manufacturer Narrative
Product complaint #: (b)(4).This report is related to a journal article, therefore no product will be returned for analysis and the manufacturing record evaluation cannot be reviewed as the lot number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Does the surgeon believe that ethicon products involved caused and/or contributed to the post-operative complications described in the article? does the surgeon believe there was any deficiency with the ethicon products used in this procedure? patient demographics: citation: acta neurochirurgica (2018); 160:2069¿2075.Doi: https://doi.Org/10.1007/s00701-018-3663-0.
 
Event Description
It was reported via a journal article: title: intracranial foreign material granulomas after cranial surgery authors: shadi al-afif, gokce hatipoglu majernik, elvis josef hermann, majid esmaeilzadeh, christian hartmann, joachim k.Krauss citation: acta neurochirurgica (2018); 160:2069¿2075.Doi: https://doi.Org/10.1007/s00701-018-3663-0.The authors presented a series of 12 patients with tumefactive foreign body granulomas after prior cranial surgery documented over a period of 13 years.A total of 12 patients (6 male and 6 female; mean age: 51 years; age range: 11¿68 years) with foreign body granulomas induced by synthetic material used in a prior surgery were identified.Patient 8, a 54-year old male patient who underwent removal of a frontal lobe hematoma and used oxidized cellulose polymer (tabotamp; ethicon) and developed foreign body granuloma with symptoms of progressive hemiparesis in all cases, total resection of the granuloma was achieved using departmental standard techniques for microsurgery, navigation, and monitoring.Mr imaging studies with gadolinium at follow-up showed no recurrence of the foreign body granulomas in all instances.Symptoms improved in all symptomatic patients.Despite its rarity, foreign body granuloma should be taken into consideration in the differential diagnosis of intracranial mass lesions especially in cases of suspected tumor recurrence after prior surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TABOTAMP SNOW ABS
Type of Device
HEMOSTATIC AGENT, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
Manufacturer (Section G)
ETHICON INC. SAN LORENZO
road 183, km. 8.3
san lorenzo 00754
Manufacturer Contact
kara ditty-bovard
p.o. box 151, route 22 west
somerville, NJ 08876
6107428552
MDR Report Key9258430
MDR Text Key167672159
Report Number2210968-2019-89278
Device Sequence Number1
Product Code LMG
Combination Product (y/n)N
PMA/PMN Number
N12159
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other
Type of Report Initial
Report Date 10/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberT2091
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/01/2019
Initial Date FDA Received10/30/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
-
-